Emergent BioSolutions shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Emergent BioSolutions (EBS) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Emergent BioSolutions
Tip: Access up to 7 years of quarterly data
All positions including Emergent BioSolutions held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Emergent BioSolutions by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.4M | 153k | 8.82 |
| 2025-06-30 | $902k | 141k | 6.38 |
| 2025-03-31 | $83k | 17k | 4.86 |
| 2024-12-31 | $116k | 12k | 9.56 |
| 2024-09-30 | $101k | 12k | 8.35 |
| 2024-03-31 | $430k | 170k | 2.53 |
| 2023-12-31 | $425k | 177k | 2.40 |
| 2023-09-30 | $814k | 239k | 3.40 |
| 2023-06-30 | $3.6M | 484k | 7.35 |
| 2023-03-31 | $5.2M | 504k | 10.36 |
| 2022-12-31 | $6.2M | 524k | 11.81 |
| 2022-09-30 | $9.2M | 482k | 19.05 |
| 2022-06-30 | $15M | 482k | 31.04 |
| 2022-03-31 | $24M | 589k | 41.06 |
| 2021-12-31 | $25M | 591k | 41.67 |
| 2021-09-30 | $30M | 594k | 50.07 |
| 2021-06-30 | $33M | 523k | 63.16 |
| 2021-03-31 | $47M | 505k | 92.74 |
| 2020-12-31 | $47M | 520k | 89.60 |
| 2020-09-30 | $56M | 538k | 103.33 |
| 2020-06-30 | $43M | 540k | 78.88 |
| 2020-03-31 | $31M | 530k | 57.86 |
| 2019-12-31 | $30M | 554k | 53.95 |
| 2019-09-30 | $31M | 583k | 52.28 |
| 2019-06-30 | $29M | 608k | 48.31 |
| 2019-03-31 | $39M | 777k | 50.52 |
| 2018-12-31 | $47M | 798k | 59.28 |
| 2018-09-30 | $56M | 852k | 65.83 |
| 2018-06-30 | $38M | 756k | 50.49 |
| 2018-03-31 | $39M | 739k | 52.65 |
| 2017-12-31 | $27M | 574k | 46.47 |
| 2017-06-30 | $19M | 567k | 33.91 |
| 2017-03-31 | $16M | 557k | 29.04 |
| 2016-12-31 | $23M | 713k | 32.84 |
| 2016-09-30 | $22M | 685k | 31.53 |
| 2016-06-30 | $19M | 670k | 28.12 |